Your browser doesn't support javascript.
loading
Increased hepatic putrescine levels as a new potential factor related to the progression of metabolic dysfunction-associated steatotic liver disease.
Núñez-Sánchez, María Ángeles; Martínez-Sánchez, María Antonia; Sierra-Cruz, Marta; Lambertos, Ana; Rico-Chazarra, Sara; Oliva-Bolarín, Alba; Balaguer-Román, Andrés; Yuste, José Enrique; Martínez, Carlos Manuel; Mika, Adriana; Frutos, María Dolores; Llamoza-Torres, Camilo J; Córdoba-Chacón, José; Ramos-Molina, Bruno.
Afiliação
  • Núñez-Sánchez MÁ; Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.
  • Martínez-Sánchez MA; Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.
  • Sierra-Cruz M; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois, Chicago, IL, USA.
  • Lambertos A; Department of Biochemistry and Molecular Biology B and Immunology, Faculty of Medicine, University of Murcia, Murcia, Spain.
  • Rico-Chazarra S; Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.
  • Oliva-Bolarín A; Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.
  • Balaguer-Román A; Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.
  • Yuste JE; Department of General and Digestive System Surgery, Virgen de la Arrixaca University Hospital, Murcia, Spain.
  • Martínez CM; Metabolomics Platform of CEBAS-CSIC, Campus Universitario de Espinardo, Murcia, Spain.
  • Mika A; Experimental Pathology Platform, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.
  • Frutos MD; Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, Medical University of Gdansk, Gdansk, Poland.
  • Llamoza-Torres CJ; Department of General and Digestive System Surgery, Virgen de la Arrixaca University Hospital, Murcia, Spain.
  • Córdoba-Chacón J; Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.
  • Ramos-Molina B; Division of Liver Diseases, Department of Gastroenterology and Hepatology, University Clinical Hospital Virgen de la Arrixaca, Murcia, Spain.
J Pathol ; 264(1): 101-111, 2024 09.
Article em En | MEDLINE | ID: mdl-39022853
ABSTRACT
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic liver condition that often progresses to more advanced stages, such as metabolic dysfunction-associated steatohepatitis (MASH). MASH is characterized by inflammation and hepatocellular ballooning, in addition to hepatic steatosis. Despite the relatively high incidence of MASH in the population and its potential detrimental effects on human health, this liver disease is still not fully understood from a pathophysiological perspective. Deregulation of polyamine levels has been detected in various pathological conditions, including neurodegenerative diseases, inflammation, and cancer. However, the role of the polyamine pathway in chronic liver disorders such as MASLD has not been explored. In this study, we measured the expression of liver ornithine decarboxylase (ODC1), the rate-limiting enzyme responsible for the production of putrescine, and the hepatic levels of putrescine, in a preclinical model of MASH as well as in liver biopsies of patients with obesity undergoing bariatric surgery. Our findings reveal that expression of ODC1 and the levels of putrescine, but not spermidine nor spermine, are elevated in hepatic tissue of both diet-induced MASH mice and patients with biopsy-proven MASH compared with control mice and patients without MASH, respectively. Furthermore, we found that the levels of putrescine were positively associated with higher aspartate aminotransferase concentrations in serum and an increased SAF score (steatosis, activity, fibrosis). Additionally, in in vitro assays using human HepG2 cells, we demonstrate that elevated levels of putrescine exacerbate the cellular response to palmitic acid, leading to decreased cell viability and increased release of CK-18. Our results support an association between the expression of ODC1 and the progression of MASLD, which could have translational relevance in understanding the onset of this disease. © 2024 The Pathological Society of Great Britain and Ireland.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Ornitina Descarboxilase / Putrescina / Progressão da Doença / Fígado Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Pathol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Ornitina Descarboxilase / Putrescina / Progressão da Doença / Fígado Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Pathol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Espanha